BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31948838)

  • 1. Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis.
    Lu H; Zhao B; Zhang J; Huang R; Wang Z; Xu H; Huang B
    Eur J Surg Oncol; 2020 Jun; 46(6):1103-1110. PubMed ID: 31948838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis.
    Yu KD; Huang S; Zhang JX; Liu GY; Shao ZM
    BMC Cancer; 2013 May; 13():240. PubMed ID: 23679207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.
    Biagi JJ; Raphael MJ; Mackillop WJ; Kong W; King WD; Booth CM
    JAMA; 2011 Jun; 305(22):2335-42. PubMed ID: 21642686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delaying adjuvant chemotherapy in advanced gastric cancer patients: Risk factors and its impact on survival outcome.
    Zhao B; Lv W; Lin J
    Curr Probl Cancer; 2020 Dec; 44(6):100577. PubMed ID: 32418615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.
    Rinninella E; Cintoni M; Raoul P; Pozzo C; Strippoli A; Bria E; Tortora G; Gasbarrini A; Mele MC
    Clin Nutr; 2020 Jul; 39(7):2045-2054. PubMed ID: 31718876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer.
    Greenleaf EK; Kulaylat AN; Hollenbeak CS; Almhanna K; Wong J
    Ann Surg Oncol; 2016 Dec; 23(13):4203-4213. PubMed ID: 27459982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis.
    Raphael MJ; Biagi JJ; Kong W; Mates M; Booth CM; Mackillop WJ
    Breast Cancer Res Treat; 2016 Nov; 160(1):17-28. PubMed ID: 27632288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer?
    Fujitani K; Kurokawa Y; Takeno A; Endoh S; Ohmori T; Fujita J; Yamasaki M; Takiguchi S; Mori M; Doki Y;
    Gastric Cancer; 2018 May; 21(3):446-452. PubMed ID: 28965205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.
    Liu TS; Wang Y; Chen SY; Sun YH
    Eur J Surg Oncol; 2008 Nov; 34(11):1208-16. PubMed ID: 18353606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trials.
    Iacovelli R; Pietrantonio F; Maggi C; de Braud F; Di Bartolomeo M
    Crit Rev Oncol Hematol; 2016 Feb; 98():24-8. PubMed ID: 26481953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
    Lu H; Sun Y; Zhu Z; Yao J; Xu H; Huang R; Huang B
    Ann Surg Oncol; 2022 Oct; 29(11):6962-6975. PubMed ID: 35723792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery.
    Kaito A; Kinoshita T; Shitara K; Shibasaki H; Nishida T
    Eur J Surg Oncol; 2017 Apr; 43(4):801-807. PubMed ID: 28187877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.
    Oba K; Paoletti X; Alberts S; Bang YJ; Benedetti J; Bleiberg H; Catalano P; Lordick F; Michiels S; Morita S; Ohashi Y; Pignon JP; Rougier P; Sasako M; Sakamoto J; Sargent D; Shitara K; Cutsem EV; Buyse M; Burzykowski T;
    J Natl Cancer Inst; 2013 Nov; 105(21):1600-7. PubMed ID: 24108812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Analysis of Real-Life Data Evaluating the Optimal Time Between Gastrectomy and Adjuvant Chemotherapy in Resected Gastric Cancer.
    Yücel KB; Sütcüoğlu O; Yazıcı O; Özet A; Özdemir N
    J Gastrointest Cancer; 2023 Dec; 54(4):1268-1275. PubMed ID: 36821038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative chemotherapy versus adjuvant chemotherapy in patients with resectable gastric cancer: A systematic review with meta-analysis.
    Wei C; Du X; Hu J; Dong Y; Chen Y; Cao B
    Crit Rev Oncol Hematol; 2024 Jun; 198():104082. PubMed ID: 37532103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
    Li Z; Shan F; Wang Y; Zhang Y; Zhang L; Li S; Jia Y; Xue K; Miao R; Li Z; Ji J
    PLoS One; 2018; 13(1):e0189294. PubMed ID: 29370182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis.
    Zhan QH; Fu JQ; Fu FM; Zhang J; Wang C
    Oncotarget; 2018 Jan; 9(2):2739-2751. PubMed ID: 29416807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis.
    Cowling J; Gorman B; Riaz A; Bundred JR; Kamarajah SK; Evans RPT; Singh P; Griffiths EA
    J Gastrointest Cancer; 2021 Mar; 52(1):41-56. PubMed ID: 32959118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
    Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK
    J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis.
    Yang Y; Yin X; Sheng L; Xu S; Dong L; Liu L
    Sci Rep; 2015 Aug; 5():12850. PubMed ID: 26242393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.